According to a large new Israeli study Pfizer’s CVOID-19 pills are hardly effective in younger adults ages 40 to 65. The data is clear that for the elderly past the age of 65 the pill reduces risk of hospitalization by 65% but such results were not replicated in younger adults. This new research!-->…
Read More...
Moderna has seeked approval from the Food and Drug Administration for their new COVID-19 booster vaccines that targets the BA.5 and BA.4 omicron subvariant. Anyone over the age of 18 would be eligible for bivalent vaccine. There are some researchers doubting the extra protection from omicron sub!-->…
Read More...
The United Kingdom became the first nation to approve the long awaited dual COVID-19 vaccine which targets the original strains of the virus but with a specialized new ability to target the Omicron variant. The U.K.’s Medicines and Healthcare products Regulatory Agency approved the usage of the!-->…
Read More...
A new large scale study on long COVID-19 has found there to be blood abnormalities associated with the infection. Researchers believe long Covid shares many similarities with myalgic encephalomyelitis/chronic fatigue syndrome which has been shown to follow after infections. The study looked at 99!-->…
Read More...
A new Omicron sub-variant has been on the rise in India called BA.2.75 or nicknamed “Centaurus”. The new sub-variant shows similar levels of contagiousness and the ability to evade immunity caused by vaccines. So far it has not had a substantial effect on India’s hospitalizations and death numbers.!-->…
Read More...
Wastewater surveillance techniques have been used in the early detection of COVID-19 outbreaks. They are now being used to monitor monkeypox infections in cities with a high propensity for monkeypox cases such as San Fransico and other cities. The use of this technology has been on the rise since!-->…
Read More...
The European Medicines Agency is recommending that the Novavax COVID-19 has a warning of 2 possible heart inflammations. On Wednesday the EMA made this statement due to a few cases of myocarditis and pericarditis after taking the shot. Novavax claims that there were no issues with heart!-->…
Read More...
According to a study posted on Tuesday, 1/3rd of people who are infected with COVID-19 will have their symptoms rebound whether they have used the antiviral Paxlovid pill or not. Around 27% of people are expected to have their symptoms rebound after having initial improvements. 12% of people have a!-->…
Read More...
The White House has decided to offer new COVID-19 booster vaccines by September. The new shots will be geared toward fighting the new extremely contagious omicron subvariants BA.5 and BA.4. The Biden administration has purchased millions of the retooled booster vaccines from pharmaceutical!-->…
Read More...
The Los Angeles County Department of Public Health has announced that the indoor COVID-19 mask mandate will not be reinstated as there has been a drop in cases in recent weeks. On July 14 the department said a new indoor mask mandate was on the table if the county continued to be placed in the!-->…
Read More...
The Centers for Disease Control and Prevention on Tuesday signed off on Novavax's two-dose Covid-19 vaccine. Dr. Rochelle Walensky, director of the CDC, along with the rest of the CDC committee voted to unanimously recommend the use of the new vaccine as a two-dose primary series in adults. The!-->…
Read More...
The University of California Irvine on Monday has reinstated indoor masking mandates for all students and staff regardless of vaccination status. UCI has joined other University of California schools such UC Riverside and UCLA that have reinstated their indoor masking mandates during the summer.!-->…
Read More...
A new study from Ontario, Canada has linked poor air quality to severe COVID-19 infection. The research published in the Canadian Medical Association Journal found that individuals who lived in areas of Ontario with high concentrations of pollutants such as fine particulate matter, nitrogen!-->…
Read More...
Pfizer announced on Monday that their long-awaited vaccine for young children was found to elicit a strong immune response with no significant adverse effects. The dose given to the children was one-tenth the dose given to adults which were found to be well tolerated by their immune systems.!-->…
Read More...